Tischler A S, Ruzicka L A, DeLellis R A
Department of Pathology, Tufts University School of Medicine, Boston, MA 02111.
Neuroscience. 1991;43(2-3):671-8. doi: 10.1016/0306-4522(91)90325-i.
Radioimmunoassay studies of cultures of PC12 pheochromocytoma cells have shown progressive increments in content and release of neurotensin in response to combinations of dexamethasone, nerve growth factor, activators of adenylate cyclase and lithium. We have studied the distribution of immunoreactive neurotensin by immunocytochemistry in cultures of PC12 cells and normal rat chromaffin cells, with two objectives: (i) to determine how changes measured by radioimmunoassay in extracts of PC12 cell populations are manifested at the level of individual cells and (ii) to determine whether normal chromaffin cells respond to combinations of agents similarly to PC12 cells. Staining for immunoreactive neurotensin is not identifiable in PC12 cells maintained in control medium or with any of the medium supplements alone. Approximately 3% of cells are stained after maintenance with dexamethasone plus nerve growth factor, verus 17% with dexamethasone plus nerve growth factor plus forskolin, and 33% with all four agents. This heterogeneity does not appear to result from clonal diversity, or to be cell cycle-dependent. Individual PC12 cells recruited to produce neurotensin in response to particular signals may, however, have passed a critical stage of differentiation toward a chromaffin cell, rather than neuronal phenotype before exposure to those signals. Staining for immunoreactive neurotensin is observed in up to 18% of normal chromaffin cells maintained with dexamethasone plus nerve growth factor, up to 45% with dexamethasone plus nerve growth factor plus forskolin, and up to 54% with all four agents. Proportions of cells stained under the various culture conditions are established before birth and in fetal cultures staining is confined for the most part to cells which do not undergo neuronal differentiation.(ABSTRACT TRUNCATED AT 250 WORDS)
对PC12嗜铬细胞瘤细胞培养物的放射免疫分析研究表明,地塞米松、神经生长因子、腺苷酸环化酶激活剂和锂的组合可使神经降压素的含量和释放逐渐增加。我们通过免疫细胞化学研究了PC12细胞和正常大鼠嗜铬细胞培养物中免疫反应性神经降压素的分布,目的有两个:(i)确定PC12细胞群体提取物中通过放射免疫分析测得的变化在单个细胞水平上是如何表现的;(ii)确定正常嗜铬细胞对试剂组合的反应是否与PC12细胞类似。在对照培养基中培养的PC12细胞或仅添加任何一种培养基补充剂时,无法识别免疫反应性神经降压素的染色。用地塞米松加神经生长因子培养后,约3%的细胞被染色,地塞米松加神经生长因子加福斯高林培养时为17%,四种试剂都使用时为33%。这种异质性似乎不是由克隆多样性导致的,也不是细胞周期依赖性的。然而,响应特定信号而被招募产生神经降压素的单个PC12细胞,在暴露于这些信号之前,可能已经经历了向嗜铬细胞而非神经元表型分化的关键阶段。在用 地塞米松加神经生长因子培养的正常嗜铬细胞中,高达18%的细胞观察到免疫反应性神经降压素染色,地塞米松加神经生长因子加福斯高林培养时高达45%,四种试剂都使用时高达54%。在各种培养条件下染色的细胞比例在出生前就已确定,在胎儿培养物中,染色大多局限于未经历神经元分化的细胞。(摘要截短于250字)